a2 Milk Co. Secures Final China Approval for Infant Formula Transfer

MT Newswires Live
06/22

a2 Milk Co. (ASX:A2M, NZE:ATM) received approval from China's State Administration for Market Regulation to transfer two China-label infant milk formula registrations tied to its Pokeno facility to its a2 brand, according to a Monday filing with the New Zealand bourse.

The company confirmed that the acquisition of the a2 Pokeno facility is now irrevocable, given the receipt of all required regulatory approvals, per the filing.

The board is expected to meet soon to consider a NZ$300 million fully franked special dividend, with timing and details to be released upon formal approval, the filing added.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10